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Haploinsufﬁciency of TNXB Is Associated
with Hypermobility Type of Ehlers-Danlos
Syndrome
To the Editor:
Ehlers-Danlos syndrome (EDS) is a heterogeneous group
of heritable connective-tissue disorders, generally affect-
ing skin, joints, and blood vessels. The most recent clas-
siﬁcation recognizes six subtypes (Beighton et al. 1998),
of which the hypermobility type (HT-EDS [formerly EDS
type III] [MIM 130020]) is the most common. This type
of EDS is similar to benign joint hypermobility syndrome
(BJHS), and both are often considered to represent the
same hyperlaxity syndrome, since no clear clinical dis-
tinction can be made (Grahame 1999). Although various
causative genes have been found in all other types of EDS,
the genetic basis of HT-EDS or BJHS remains unexplained
(Steinmann et al. 2002). One family has been described
that has a missense mutation in COL3A1 (Narcisi et al.
1994), resulting in a phenotype that resembles HT-EDS,
without obvious vascular complications. Mutations in
COL3A1 generally result in the severe vascular type of
EDS (MIM 130050). To our knowledge, no other cases
of COL3A1 mutations in HT-EDS have been reported.
Recently, we showed that deﬁciency of the extracel-
lular-matrix protein tenascin-X (TNX), encoded by the
TNXB gene, causes a new type of recessively inherited
EDS (Schalkwijk et al. 2001). Patients with complete
deﬁciency of TNX showed marked joint hypermobil-
ity, skin hyperextensibility, and easy bruising. The ab-
sence of atrophic scars and recessive inheritance distin-
guishes TNX deﬁciency from the classical type of EDS.
In our initial report (Schalkwijk et al. 2001), only a few
heterozygous family members were available for exam-
ination. Here, we have examined all 20 heterozygous
family members (individuals from families A–D in table
1) who were available for further study, regardless of clin-
ical symptoms; in all of these individuals, we have found
signiﬁcantly reduced serum TNX levels (56% 6% vs.
100%  14% in the control population; , byP ! .001
Student’s t test) (ﬁg. 1f), and, in 17 of them, we have
conﬁrmed heterozygosity for a truncating TNXB muta-
tion (table 1). Clinical examination revealed generalized
joint hypermobility in nine family members (45%), using
the Beighton score (Beighton et al. 1973), for HT-EDS,
or the Brighton criteria (Grahame et al. 2000), for BJHS
(table 1 and ﬁg. 1e). Skin hyperextensibility and easy
bruising, frequently seen in the individuals with complete
TNX deﬁciency, were absent. A number of patients with
haploinsufﬁciency had recurring joint dislocations and
chronic joint pain, as are seen in HT-EDS and BJHS. Only
four family members carrying two normal TNXB alleles
were available for study, of whom none had hypermo-
bility. The local medical ethics committee (CMO Regio
Arnhem-Nijmegen) approved the study protocol, and
informed consent was obtained from all patients.
A striking ﬁnding is that 0 of the 6 males with hap-
loinsufﬁciency fulﬁlled the clinical criteria for HT-EDS
or BJHS, whereas 9 of 14 (64%) females were positive.
This ﬁnding is in accordance with previous population-
based studies that show a female preponderance in joint
hypermobility syndromes (Larsson et al. 1987; Rikken-
Bultman et al. 1997). In a control group of 30 unaffected
females of the same age as the females with haploinsuf-
ﬁciency in the present study, we found no individuals
with a Beighton score 14. This indicates that the prev-
alence of generalized joint hypermobility in a population
of females with haploinsufﬁciency is signiﬁcantly higher
than in a control population ( , by x2 test). NoP ! .001
sex differences in serum TNX levels in unaffected in-
dividuals and individuals with haploinsufﬁciency were
found (not shown).
Because our observations in families carrying pre-
viously described TNXB mutations suggested an as-
sociation between TNXB haploinsufﬁciency and joint
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Table 1
Clinical and Molecular Findings in Individuals with TNXB Haploinsufﬁciency/Reduced Serum TNX Levels
Individuala
(Sex)
Year
of Birth Mutation
Beighton
Score
TNX Level
(% of Control) Clinical Feature(s)
AIII2 (F) 1961 [GT44906] ins 5/9 52 Velvety skin, piezogenic papules, back pain
AIII3 (M) 1964 [GT44906] ins 4/9 57 Loss of pliancy, Raynaud phenomenon
AIII6 (F) 1974 [GT44906] ins 6/9 59 Velvety skin, Raynaud phenomenon
AIII7 (F) 1977 [GT44906] ins 5/9 52 Striae
AIII8 (F) 1981 [GT44906] ins 5/9 50 Ankle sprains, knee pain
AIII9 (F) 1984 [GT44906] ins 5/9 68 Velvety skin
BI4 (M) 1931 Unknown 0/9 56 Multiple ankle sprains
BIII1 (F) 1976 Unknown 5/9 65
BIII2 (F) 1979 Unknown 5/9 62 Wheelchair dependent, joint pain
BIII3 (F) 1981 30-kb del 5/9 62 Joint pain
CI1 (M) 1919 [AA56063] del 0/9 55
CI5 (F) 1924 [AA56063] del ND 54
CII1 (F) 1944 [AA56063] del 1/9 46
CIII3 (F) 1978 [AA56063] del 3/9 45 Piezogenic papules, lymphedema
CIII4 (F) 1980 [AA56063] del 6/9 53 Velvety skin, multiple (sub)luxations
CIII5 (M) 1981 [AA56063] del 0/9 57
DI1 (M) 1919 30-kb del 0/9 53 Velvety skin
DI2 (F) 1931 30-kb del 0/9 54 Multiple fractures
DII1 (F) 1962 30-kb del 2/9 59
DII2 (M) 1964 30-kb del 2/9 61 Piezogenic papules
E (F) 1961 30-kb del 3/9 58 Chronic joint pain, multiple (sub)luxations, wheelchair dependent,
HT-EDS/BJHS according to Brighton criteria
F (F) 1970 [AA56063] del 6/9 52
G1 (F) 1972 Unknown 6/9 56 Luxations, velvety skin, piezogenic papules
G2 (F) 1977 Unknown 6/9 61 Chronic pain, subluxations of multiple joints
H (F) 1961 Unknown 2/9 64 Wheelchair dependent, chronic musculoskeletal pain, shoulder
luxations, HT-EDS/BJHS according to Brighton criteria
I (F) 1954 Unknown ND 65 Diagnosis of HT-EDS
J (F) 1974 Unknown ND 54 Diagnosis of HT-EDS
a Pedigrees for families A–D are depicted in ﬁgure 1. Patients E–J were identiﬁed in a cohort with HT-EDS. G2 is a sister of G1 and was identiﬁed
independently of the screening of the 80 patients with HT-EDS/BJHS. We examined all patients available for study except individuals I and J.
b ND p not determined.
hypermobility, we wondered about the prevalence of
TNXB haploinsufﬁciency in patients with HT-EDS. We
measured serum TNX levels (by ELISA) in an unselect-
ed cohort of 80 patients with HT-EDS who were recruit-
ed through the Dutch organization for patients with
EDS. All patients were diagnosed with HT-EDS by a
medical specialist, and ∼90% were female. Although the
mean serum TNX level was not different in the cohort
with HT-EDS overall ( ) (ﬁg. 1f), six of99.4% 19.7%
these patients (7.5% [all female]) had serum TNX levels
12.5 SDs (65%) below the mean for unaffected individ-
uals. On the basis of the normal distribution of serum
TNX levels, only 0.6% of individuals would be expect-
ed to have such low serum TNX levels, which is signif-
icantly less than the frequency found in the population
with HT-EDS described in the present study ( ,P ! .001
by Fisher’s exact test).
Clinically, patients with reduced TNX levels showed
hypermobile joints, often associated with joint sublux-
ations and chronic musculoskeletal pain (table 1). The
clinical ﬁndings in these patients differ from those with
complete TNX deﬁciency. Patients with haploinsufﬁcien-
cy do not have skin hyperextensibility and lack the easy
bruising seen in patients with TNX deﬁciency. In addi-
tion, TNXB haploinsufﬁciency is expected to be an auto-
somal dominant trait, which is in accordance with the
observed mode of inheritance of HT-EDS and BJHS.
On screening for the presence of a 30-kb deletion
described previously (Burch et al. 1997; Schalkwijk et
al. 2001), we found that this deletion was present in
one of these six patients. The 30-kb deletion creates
a fusion gene of TNXB and XA, a partial duplicate
of TNXB. The XA gene has an internal deletion that
truncates its ORF, rendering XA and the fusion gene
nonfunctional (Gitelman et al. 1992). The deleted al-
lele also lacks CYP21, so this individual is also a car-
rier for congenital adrenal hyperplasia. Subsequently,
we PCR ampliﬁed and directly sequenced the coding
regions and the intron-exon boundaries of TNXB in
the other ﬁve patients presumed to have haploinsuf-
ﬁciency (for primers used, see Schalkwijk et al. 2001).
One patient (individual F in table 1) was heterozygous
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Figure 1 TNXB haploinsufﬁciency and generalized joint hypermobility. a–d, Pedigrees of families A–D (also see table 1). e, Joint hy-
permobility in individual III9 from family A. f, Distribution of serum TNX levels in control population, population with HT-EDS, and hetero-
zygous (Het) population. Values are given as percentage of the control mean.
for a 2-bp deletion, [AA56063] del, in exon 8, result-
ing in a premature stop codon at the position of amino
acid 1231. In the other four patients, we were unable
to identify mutations in TNXB. These patients may have
mutations, in regulatory sequences or in exons of the
TNXB gene, that have not yet been identiﬁed, or they
may represent the extreme in normal variation of TNX
expression.
In conclusion, in the present study, we have reported
a genetic defect associated with HT-EDS or BJHS. On
the basis of the observed phenotype in patients with com-
plete TNX deﬁciency and the high prevalence of gener-
alized joint hypermobility in heterozygous females, this is
likely to be a causative relationship. Reduced TNX ex-
pression could disturb deposition of collagen (Mao et al.
2002) and the elastic ﬁber network (Burch et al. 1997),
as has been shown for complete TNX deﬁciency, resulting
in increased laxity of ligaments and tendons. TNXB hap-
loinsufﬁciency is dominantly inherited and appears to pro-
duce clinical ﬁndings primarily in women, consistent with
clinical descriptions of HT-EDS. Although we identiﬁed
inactivating TNX mutations in only 2.5% of this cohort
with HT-EDS, 7.5% had serum TNX levels low enough
to affect collagen metabolism. The present study demon-
strates that TNXB haploinsufﬁciency is associated with
HT-EDS and suggests that locus heterogeneity exists for
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this disorder, as it does for other types of EDS (Byers
1994).
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